文献速递肿瘤 PET/CT神经核医学

18F-MFBG垂体摄取持续增高属生理性正常变异

A Consistently Elevated Pineal Gland Uptake of 18F-MFBG as a Physiological Normal Variant.
PubMed 文献 · Clin Nucl Med · 2026-10-20

一名3岁高危神经母细胞瘤女童在临床试验中接受18F-MFBG PET/CT疗效评估,扫描发现垂体局灶性摄取增高。同期68Ga-DOTATATE PET/CT亦见相同摄取,脑MRI无转移征象,随访18F-MFBG PET/CT显示同一区域摄取持续增高且无间隔变化,支持该垂体活性为生理性正常变异而非病理病灶。

要点

  • 18F-MFBG PET/CT可见垂体局灶性摄取增高,可为生理性正常变异。
  • 同期68Ga-DOTATATE PET/CT一致摄取及阴性脑MRI支持生理性判断。
  • 随访18F-MFBG PET/CT同一区域摄取持续无变化,进一步排除病理病灶。

核心结论

  • 3岁高危神经母细胞瘤女童的垂体18F-MFBG摄取持续增高,经综合判断为生理性正常变异而非病理病灶。

研究设计与样本

  • 一名3岁高危神经母细胞瘤女童在临床试验中接受18F-MFBG PET/CT疗效评估的病例报告。

主要发现

  • 18F-MFBG PET/CT显示垂体局灶性摄取增高,同期68Ga-DOTATATE PET/CT亦见相同摄取。
  • 脑MRI未见转移征象,随访18F-MFBG PET/CT显示同一区域摄取持续增高且无间隔变化。

关键数值与推荐

  • 阴性脑MRI、一致的68Ga-DOTATATE生理性摄取及系列18F-MFBG PET/CT稳定表现共同支持生理性正常变异判断。

临床怎么用

  • 核医学科医生解读18F-MFBG PET/CT时,遇垂体局灶性摄取增高应结合MRI及系列影像,避免误判为转移灶。

局限性

  • 本文为单例病例报告,结论的普遍适用性需更多病例验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 3-year-old girl with high-risk neuroblastoma underwent 18F-MFBG PET/CT for therapy response evaluation as part of a clinical trial. The scan revealed focal increased uptake in the pineal gland, which was also observed on a concurrent 68Ga-DOTATATE PET/CT. Brain MRI showed no signs of metastasis, and importantly, follow-up 18F-MFBG PET/CT demonstrated consistently elevated uptake in the same region without interval change. These combined findings, negative MRI, concordant physiological 68Ga-DOTATATE uptake, and stable appearance on serial 18F-MFBG PET/CT, support the interpretation of this pineal gland activity as a physiological normal variant rather than a pathologic lesion.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Zhang K, Wang X, Zhang B, et al. A Consistently Elevated Pineal Gland Uptake of 18F-MFBG as a Physiological Normal Variant. Clin Nucl Med. 2026. PMID: 42912571. doi:10.1097/RLU.0000000000006717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。